查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1946426

環己胺市場 - 全球產業規模、佔有率、趨勢、機會及預測（按類型、最終用戶產業、地區和競爭格局分類，2021-2031年）

Cyclamate Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User Industry, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球環Cyclamate市場預計將從 2025 年的 20.8 億美元成長到 2031 年的 25.8 億美元，複合年成長率為 3.66%。

這種高強度人工甜味劑，化學名稱為環己基氨基磺酸的鈣鹽或鈉鹽，其甜度約為蔗糖的30至50倍。其市場擴張主要得益於其在高溫加工過程中優異的穩定性，使其成為烘焙點心的必備原料，並且與其他合成甜味劑相比具有顯著的成本效益。此外，它還能協同掩蓋糖精等物質的苦澀後味，因此被廣泛應用於各種醫藥和飲料配方中。中國食品添加劑及配料協會指出，其貿易平台在2024年吸引了超過1,500家參展，顯示中國擁有強大的生產能力，能夠滿足日益成長的全球需求。

市場概覽
預測期 2027-2031
市場規模：2025年 20.8億美元
市場規模：2031年 25.8億美元
複合年成長率：2026-2031年 3.66%
成長最快的細分市場 飲食
最大的市場 北美洲

儘管經濟指標向好，但由於世界各地監管法規的差異，市場仍面臨許多障礙。美國食品藥物管理局(FDA) 持續禁用Cyclamate，不僅使北美龐大的消費群體無法接觸到該產品，也加劇了人們對該產品安全性的擔憂。這些監管障礙有效地阻礙了該產品的國際市場拓展和普及，導致生產商和經銷商面臨市場分散的困境。

市場促進因素

全球糖尿病和肥胖症發生率的不斷上升，正成為Cyclamate市場的主要驅動力，促使製造商重新設計產品，推出零卡路里替代品。隨著公共衛生機構將減少糖分攝取列為優先事項，食品飲料產業正迅速採用高甜度甜味劑，以在不犧牲風味的前提下降低卡路里含量。根據國際糖尿病聯盟 (IDF) 預測，到 2024 年，全球 20 至 79 歲的成年人中將有約 5.89 億人患有糖尿病，這使得低升糖指數食品的選擇需求迫切。這種健康意識的轉變也體現在消費者的行為中：英聯食品配料公司 (Ingredion) 發布的 2024 年報告顯示，標有「減血糖值」字樣的包裝食品銷量較 2020 年成長超過 30%，凸顯了商業性對使用Cyclamate甜味劑產品的強勁需求。

同時，與糖和天然甜味劑相比，Cyclamate的價格優勢和成本效益仍然是其在工業應用中持續普及的關鍵因素。在價格敏感型市場和糖果甜點、碳酸飲料等大眾消費品領域，這種甜味劑能夠以遠低於甜菊糖或蔗糖的成本提供濃郁的甜味，使製造商能夠抵禦原料成本波動的影響，從而保障利潤率。強大的供應鏈基礎進一步鞏固了這一市場地位，並透過規模經濟維持了其經濟優勢。例如，領先的生產商金時化工（江蘇）有限公司表示，其環己Cyclamate磺酸鈉的年產能將在2024年保持在4萬噸，從而確保為全球買家提供可靠且價格合理的供應。

市場挑戰

由於區域監管差異，特別是美國食品藥物管理局(FDA) 持續實施的禁令，全球環己Cyclamate市場面臨嚴峻挑戰。這種市場分散化迫使製造商為核准的市場（亞洲和歐洲）以及北美市場維護雙線產品，從而阻礙了市場擴張。這些要求抵消了通常透過標準化全球配方實現的規模經濟效益，增加了跨國食品飲料公司的生產成本和物流複​​雜性。

此外，美國市場對該成分安全性的排斥加劇了人們對其安全性的歷史偏見，即使在允許使用該成分的地區，這種偏見也會影響消費者的看法。這種聲譽障礙對消費模式產生了負面影響，阻礙了潛在的推廣應用。根據國際食品資訊理事會（IFIC）2024年的數據，31%的美國消費者因安全顧慮而減少或停止攝取低熱量和無熱量甜味劑。這凸顯了主要經濟體監管部門的拒絕如何加劇負面情緒，並最終限制此類成分的銷售成長和國際普及。

市場趨勢

協同增效的多醣體混合物正在改變市場格局。製造商通常將Cyclamate與其他高甜度甜味劑混合使用，以獲得最佳的感官特性。Cyclamate磺酸鈉因其穩定性而備受推崇，但目前的市場動態主要集中在將其與糖精進行戰略性組合，以抵消單一甜味劑使用時常見的金屬後味。由於關鍵混合夥伴的監管政策更新，這種混合策略在近期獲得了顯著的商業性支持。 2024年，國際甜味劑協會報告稱，歐洲食品安全局重申了糖精的安全性，並將可接受攝取量從每公斤體重5毫克提高到9毫克。這項措施擴大了環己基氨基磺酸鈉-糖精混合物在歐洲食品和飲料行業的應用範圍和允許使用量。

同時，Cyclamate作為苦味掩蔽劑在藥物中的應用日益廣泛，催生了對Cyclamate磺酸鈉的特殊需求，尤其是在老年和兒童口服製劑領域，因為口感直接影響患者的治療依從性。藥物研發人員正積極將環己基氨基磺酸鈉基輔料應用於複雜的現代活性藥物成分（API）中，以抵消其令人不悅的口感，其作用也從簡單的甜味劑發展到功能性味覺修飾。藥物研發中普遍存在的偏好問題凸顯了此應用的重要性。歐洲醫學協會於2024年10月在《醫學研究檔案》上發表的一項回顧性分析發現，在65%的受調查活性藥物成分中，苦味是主要的掩味障礙，這凸顯了新型藥物對Cyclamate受體阻斷特性的需求日益成長。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球環胺市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（環己基氨基磺酸、環己基氨基磺酸鈉、環己基氨基磺酸鈣、其他）
    • 依最終使用者產業（食品飲料、醫療、化妝品等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美環胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲環胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區環胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲環胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲環胺市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球環胺市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • PT. Batang Alum Industrie
  • Food Chem International Corporation
  • Productos Aditivos
  • Rasna Private Limited
  • Hangzhou Garden Corporation
  • Shanghai Rich Chemicals
  • Jinan Haohua Industry Co. Ltd.
  • Hangzhou Union Biotechnology
  • Xuchang Ruida Biology Technology
  • Rainbow Rich Industrial Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 15202

The Global Cyclamate Market is projected to expand from a valuation of USD 2.08 Billion in 2025 to USD 2.58 Billion by 2031, reflecting a CAGR of 3.66%. Chemically identified as the calcium or sodium salt of cyclamic acid, this high-intensity artificial sweetener delivers a sweetness potency approximately 30 to 50 times that of sucrose. Market expansion is primarily driven by its exceptional stability during high-temperature processing, rendering it indispensable for baked goods, alongside its substantial cost efficiency compared to other synthetic options. Additionally, its ability to synergistically mask the bitter aftertaste of substances like saccharin fuels its widespread adoption in various pharmaceutical and beverage formulations. Highlighting the industry's scale, the China Food Additives and Ingredients Association noted that in 2024, their trade platform hosted over 1,500 exhibitors, demonstrating the strong manufacturing capacity available to satisfy growing global requirements.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.08 Billion
Market Size 2031USD 2.58 Billion
CAGR 2026-20313.66%
Fastest Growing SegmentFood and Beverage
Largest MarketNorth America

Despite these positive economic indicators, the market encounters significant obstacles due to regulatory discrepancies across global jurisdictions. The enduring prohibition of cyclamate by the United States Food and Drug Administration not only blocks access to the substantial North American consumer base but also reinforces historical safety apprehensions. These regulatory barriers effectively hinder wider international acceptance and adoption of the product, creating a divided global landscape for manufacturers and distributors.

Market Driver

The rising global incidence of diabetes and obesity acts as a major catalyst for the cyclamate market, pushing manufacturers to reformulate their offerings with zero-calorie substitutes. With public health entities prioritizing sugar reduction, the food and beverage sector is rapidly integrating high-intensity sweeteners to lower caloric content without sacrificing flavor. According to the International Diabetes Federation, roughly 589 million adults aged 20-79 were living with diabetes globally in 2024, creating an urgent demographic need for low-glycemic dietary choices. This health-conscious transition is evident in consumer behavior; Ingredion reported in 2024 that sales of packaged goods with reduced-sugar claims had increased by over 30% since 2020, highlighting the commercial demand for cyclamate-sweetened products.

Concurrently, the price advantage and cost-effectiveness of cyclamate compared to sugar and natural sweeteners remain vital for its continued industrial application. In markets sensitive to price and high-volume sectors like confectionery and carbonated soft drinks, the sweetener's capacity to provide intense sweetness at a fraction of the cost of stevia or sucrose enables manufacturers to safeguard margins against volatile raw material costs. This market position is bolstered by strong supply chain infrastructures that preserve this economic benefit through economies of scale. For example, Golden Time Chemical (Jiangsu) Co., Ltd., a leading producer, reported maintaining an annual production capacity of 40,000 tons of sodium cyclamate in 2024, guaranteeing a reliable and affordable supply for global buyers.

Market Challenge

The Global Cyclamate Market contends with significant difficulties arising from regulatory disparities across different regions, particularly the persistent ban enforced by the United States Food and Drug Administration. This fragmentation impedes market expansion by compelling manufacturers to maintain dual product lines-one for approved markets like Asia and Europe, and another for the substantial North American sector. Such requirements negate the economies of scale usually gained through standardized global formulations, resulting in escalated production costs and increased logistical complexity for multinational food and beverage companies.

Moreover, exclusion from the U.S. market reinforces historical stigma regarding the ingredient's safety, impacting consumer views even in jurisdictions where it is permitted. This reputational hurdle negatively influences consumption patterns and discourages potential uptake. Data from the International Food Information Council in 2024 indicated that 31% of U.S. consumers reduced or ceased consumption of low- and no-calorie sweeteners specifically due to safety concerns. This highlights how regulatory rejection in a major economy perpetuates negative sentiment, ultimately constraining the ingredient's volume growth and broader international adoption.

Market Trends

The trend of adopting synergistic multi-sweetener blending formulations is transforming the market, as manufacturers frequently combine cyclamate with other high-intensity sweeteners to achieve optimized sensory profiles. Although cyclamate is prized for its stability, current market dynamics focus on its strategic pairing with saccharin to neutralize the metallic aftertaste often found in single-sweetener applications. This formulation strategy recently gained significant commercial support due to regulatory updates concerning its main blending partner. In 2024, the International Sweeteners Association noted that the European Food Safety Authority reaffirmed saccharin's safety and raised its Acceptable Daily Intake from 5 to 9 mg/kg body weight per day, a move that expands the application scope and permissible volume for these cyclamate-saccharin blends within the European food and beverage industry.

At the same time, the increasing use of cyclamate as a bitterness masking agent in pharmaceuticals is generating specialized demand, especially for geriatric and pediatric oral formulations where taste directly impacts therapeutic compliance. Drug developers are actively incorporating cyclamate-based excipients to counteract the unpleasant taste profiles of complex modern active pharmaceutical ingredients (APIs), advancing from simple sweetening to functional taste modification. The critical nature of this application is highlighted by prevalent palatability issues in drug creation. A retrospective analysis published in the 'Medical Research Archives' by the European Society of Medicine in October 2024 found that bitterness was the primary taste-masking obstacle for 65% of the drug actives reviewed, emphasizing the growing need for cyclamate's receptor-blocking properties in new medicinal products.

Key Market Players

  • PT. Batang Alum Industrie
  • Food Chem International Corporation
  • Productos Aditivos
  • Rasna Private Limited
  • Hangzhou Garden Corporation
  • Shanghai Rich Chemicals
  • Jinan Haohua Industry Co. Ltd.
  • Hangzhou Union Biotechnology
  • Xuchang Ruida Biology Technology
  • Rainbow Rich Industrial Ltd

Report Scope

In this report, the Global Cyclamate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cyclamate Market, By Type

  • Cyclamic Acid
  • Sodium Cyclamate
  • Calcium Cyclamate
  • Others

Cyclamate Market, By End User Industry

  • Food and Beverage
  • Healthcare
  • Cosmetics
  • Others

Cyclamate Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cyclamate Market.

Available Customizations:

Global Cyclamate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cyclamate Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Cyclamic Acid, Sodium Cyclamate, Calcium Cyclamate, Others)
    • 5.2.2. By End User Industry (Food and Beverage, Healthcare, Cosmetics, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cyclamate Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End User Industry
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cyclamate Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User Industry
    • 6.3.2. Canada Cyclamate Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User Industry
    • 6.3.3. Mexico Cyclamate Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User Industry

7. Europe Cyclamate Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End User Industry
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cyclamate Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User Industry
    • 7.3.2. France Cyclamate Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User Industry
    • 7.3.3. United Kingdom Cyclamate Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User Industry
    • 7.3.4. Italy Cyclamate Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User Industry
    • 7.3.5. Spain Cyclamate Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User Industry

8. Asia Pacific Cyclamate Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End User Industry
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cyclamate Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User Industry
    • 8.3.2. India Cyclamate Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User Industry
    • 8.3.3. Japan Cyclamate Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User Industry
    • 8.3.4. South Korea Cyclamate Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User Industry
    • 8.3.5. Australia Cyclamate Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User Industry

9. Middle East & Africa Cyclamate Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End User Industry
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cyclamate Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User Industry
    • 9.3.2. UAE Cyclamate Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User Industry
    • 9.3.3. South Africa Cyclamate Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User Industry

10. South America Cyclamate Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End User Industry
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cyclamate Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User Industry
    • 10.3.2. Colombia Cyclamate Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User Industry
    • 10.3.3. Argentina Cyclamate Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User Industry

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cyclamate Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. PT. Batang Alum Industrie
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Food Chem International Corporation
  • 15.3. Productos Aditivos
  • 15.4. Rasna Private Limited
  • 15.5. Hangzhou Garden Corporation
  • 15.6. Shanghai Rich Chemicals
  • 15.7. Jinan Haohua Industry Co. Ltd.
  • 15.8. Hangzhou Union Biotechnology
  • 15.9. Xuchang Ruida Biology Technology
  • 15.10. Rainbow Rich Industrial Ltd

16. Strategic Recommendations

17. About Us & Disclaimer